Actively Recruiting
Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis
Led by Qianfoshan Hospital · Updated on 2025-07-04
140
Participants Needed
1
Research Sites
194 weeks
Total Duration
On this page
Sponsors
Q
Qianfoshan Hospital
Lead Sponsor
S
Shanghai Pulmonary Hospital, Shanghai, China
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study aims to reveal the immune and inflammatory regulatory molecular mechanisms related to the progression of allergic bronchopulmonary aspergillosis (ABPA), and to build a precision typing based on inflammation and identify the biomarkers of typing, and to explore the clinical outcomes of different inflammatory phenotypes.
CONDITIONS
Official Title
Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Meets the diagnostic criteria for allergic bronchopulmonary aspergillosis.
- Meets the diagnostic criteria for fungal-sensitized asthma.
You will not qualify if you...
- Human immunodeficiency virus infection.
- Malignant tumor.
- Blood system disease.
- Autoimmune system disease.
- History of pulmonary tuberculosis.
- Patients with a history of smoking or still smoking.
- Invasive pulmonary fungal disease.
- Contraindications to electronic bronchoscopy.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, #16766, Jingshi Road, Jinan City, Shandong Province, China
Jinan, Shandong, China, 250014
Actively Recruiting
Research Team
Q
Qian Qi, Prof.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here